Cleared Traditional

RayCare 3.1 (K200487) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200487 · RaySearch Laboratories AB (PUBL) · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
104d
Days
Class 2
Risk

K200487 is an FDA 510(k) clearance for the RayCare 3.1. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by RaySearch Laboratories AB (PUBL) (Stockholm, SE). The FDA issued a Cleared decision on June 10, 2020 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all RaySearch Laboratories AB (PUBL) devices

Submission Details

510(k) Number K200487 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2020
Decision Date June 10, 2020
Days to Decision 104 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 107d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 113
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K200487.
CORVUS
K201350 · Best Nomos · Sep 2020
Syngo.via RT Image Suite
K201444 · Siemens Medical Solutions USA, Inc. · Aug 2020
Eclipse Treatment Planning System v16.1
K201607 · Varian Medical Systems, Inc. · Jul 2020
Panther Stereotactic
K193459 · Prowess, Inc. · Apr 2020
ClearCalc
K193640 · Radformation, Inc. · Apr 2020
Eclipse Treatment Planning System v16.0
K200608 · Varian Medical Systems, Inc. · Apr 2020